Dermawave Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-12-2024
- Paid Up Capital ₹ 0.15 M
as on 25-12-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.20 M
as on 25-12-2024
- Revenue 56.42%
(FY 2020)
- Profit 59.26%
(FY 2020)
- Ebitda 27.03%
(FY 2020)
- Net Worth 102.88%
(FY 2020)
- Total Assets 22.50%
(FY 2020)
About Dermawave
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹3.20 M.
Mona Sharma, Sumit Sharma, Dhiraj Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100HR2017PTC067112
- Company No.
067112
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panipat, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Dermawave Private Limited offer?
Dermawave Private Limited offers a wide range of products and services, including Fitness Clubs and Beauty Parlours, Beauty Services, Medical Surgery & Treatment Centres, Medical Treatment Services, Medical Consultants & Clinics, Hair Treatment, Dermatology Treatment Services, Skin Treatment Solution, Salon, Spa Kits & Equipments, Body Tattoo Accessories.
Who are the key members and board of directors at Dermawave?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mona Sharma  | Director | 17-Jan-2017 | Current |
| Sumit Sharma | Director | 17-Jan-2017 | Current |
| Dhiraj Kumar | Additional Director | 04-May-2022 | Current |
| Satish Kumar | Director | 17-Jan-2017 | Current |
Financial Performance of Dermawave.
Dermawave Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 56.42% increase. The company also saw a substantial improvement in profitability, with a 59.26% increase in profit. The company's net worth Soared by an impressive increase of 102.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dermawave?
In 2020, Dermawave had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Mar 2018 | ₹3.20 M | Open |
How Many Employees Work at Dermawave?
Unlock and access historical data on people associated with Dermawave, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dermawave, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dermawave's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
